Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the 2024 PNS Annual Meeting from 22nd to 25th June in Montreal, Canada. This event brings together global experts and specialists in peripheral neuropathy to discuss the latest advancements and research.

Attendees will include clinicians, researchers, and industry professionals dedicated to improving the understanding and treatment of peripheral nerve disorders.

If you would like to connect with Dr. Taubel during the event, please reach out to arrange a meeting.

To find out more, click here.

Latest news

Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy

September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event